Sturm, Ruger & Company, Inc., together with its subsidiaries, designs, manufactures, and sells firearms under the Ruger name and trademark in the United States. It operates in two segments, Firearms and Castings. The company offers single-shot, autoloading, bolt-action, and modern sporting rifles; rimfire and centerfire autoloading pistols; single-action and double-action revolvers; over-under shotguns; and firearms accessories and replacement parts, as well as manufactures lever-action rifles under the Marlin name and trademark. It also provides steel investment castings and metal injection molding (MIM) parts. The company sells its firearm products to the commercial sporting market through independent wholesale distributors; and its investment castings and MIM parts directly or through manufacturers' representatives. It also exports its firearm products through a network of selected commercial distributors and directly to foreign customers comprising primarily of law enforcement agencies and foreign governments. The company was founded in 1949 and is based in Southport, Connecticut.…
Beretta Secures Path to 25% Stake in Sturm, Ruger & Company, Inc. (RGR) Under Strategic Agreement
Sturm, Ruger & Company (NYSE: RGR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 1,780 employees.
The shares were at 51.66 USD on 20 November 2026, up 71.5% over 52 weeks. Its 52-week range is 28.33 USD to 54.00 USD: the price is 4.3% below the high and 82.4% above the low.
At a market capitalisation of 825.44M USD, it trades at 51.7 times trailing earnings and 25.1 times forward earnings. The median trailing P/E of its 20 largest Aerospace & Defense peers is 30.8, a premium of 67% for RGR. It pays a dividend yielding 1.39% (it pays out 44% of its earnings), against a median of 1.55% among the dividend payers in that peer group.
Sturm, Ruger & Company reports return on equity of -1.5%, an operating margin of 3.0% and revenue up 16.5% year over year.
It holds more cash than debt, a net cash position of 99.56M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 51.50 USD is 0.3% below the current price. The next earnings report is expected on 17 February 2027.